Skip to main content
. 2013 Aug 26;89(1):7–12. doi: 10.1002/ajh.23582

Figure 1.

Figure 1

Proportion of patients with ≥2.0 g/dL increase in hemoglobin at any time from Baseline to Week 5 (intent-to-treat population).